Ginsenoside Rb1 enhanced immunity and altered the gut microflora in mice immunized by H1N1 influenza vaccine
PeerJ · 17.10.2023 · 11 · e16226
DOI: 10.7717/peerj.16226 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, online erschienen am 17.10.2023. Verfasst von Chuanqi Wan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, Xuhui, China. Hauptthemen laut MEDLINE: Influenza, Human, Influenza Vaccines, Influenza A Virus, H1N1 Subtype, Gastrointestinal Microbiome. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Science and Technology Project of Zhejiang Province, Key Research Projects of Zhejiang Chinese Medical University.
Abstract (Originalsprache)
Background
Influenza is an acute infectious respiratory disease caused by the influenza virus that seriously damages human health, and the essential way to prevent influenza is the influenza vaccine. Vaccines without adjuvants produce insufficient specific antibodies and therefore require adjuvants to boost antibody titers. Microbes and hosts are a community that needs to “promote bacteria,” which could provide new value for the immune effect.
Methods
(1) The H1N1 influenza vaccine, in combination with Ginsenoside Rb1, was co-injected into mice intraperitoneally (I.P.). Then, immunoglobulin G and antibody subtype levels were tested by enzyme-linked immunosorbent assay (ELISA). Moreover, mice were infected with a lethal dose of the H1N1 influenza virus (A/Michigan/45/2015), and survival status was recorded for 14 days. Lung tissues were stained by hematoxylin and eosin (H&E), and ELISA detected inflammatory factor expression levels. (2) Mice were immunized with Ginsenoside Rb1 combined with quadrivalent influenza inactivated vaccine(IIV4), and then IgG levels were measured by ELISA. (3) Fresh stool was collected for fecal 16S rDNA analysis.
Results
Ginsenoside Rb1 boosted IgG and antibody subtypes in the H1N1 influenza vaccine, improved survival of mice after virus challenge, attenuated lung histopathological damage, and reduced inflammatory cytokines expression in IL-6 and TNF- α . The results of 16S rDNA showed that Rb1 decreased species diversity but increased species richness compared to the PBS group and increased the abundance of Akkermansiaceae and Murbaculaceae at the Family and Genus levels compared with the HA+Alum group.
Conclusion
Ginsenoside Rb1 has a boosting effect on the immune efficacy of the H1N1 influenza vaccine and is promising as a novel adjuvant to regulate the microecological balance and achieve an anti-infective effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, Xuhui, China.
- Department of Emergency, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Shangcheng, China.
- Department of ICU, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Shangcheng, China.
- The First Affiliated Hospital, Zhejiang University, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, School of…
- Institute of Critical Care, Shanghai University of Traditional Chinese Medicine, Shanghai, Xuhui, China.
Förderung
- The Science and Technology Project of Zhejiang Province
- Key Research Projects of Zhejiang Chinese Medical University
Zitieren
APA
Wan, C., Lu, R., Zhu, C., Wu, H., Shen, G., Yang, Y., Wu, X., Fang, B., & He, Y. (2023). Ginsenoside Rb1 enhanced immunity and altered the gut microflora in mice immunized by H1N1 influenza vaccine. PeerJ, 11, e16226. https://doi.org/10.7717/peerj.16226
Vancouver
Wan C, Lu R, Zhu C, Wu H, Shen G, Yang Y, et al. Ginsenoside Rb1 enhanced immunity and altered the gut microflora in mice immunized by H1N1 influenza vaccine. PeerJ. 2023;11:e16226. doi:10.7717/peerj.16226
BibTeX
@article{Wan2023,
author = {Wan, Chuanqi and Lu, Rufeng and Zhu, Chen and Wu, Haibo and Shen, Guannan and Yang, Yang and Wu, Xiaowei and Fang, Bangjiang and He, Yuzhou},
title = {Ginsenoside Rb1 enhanced immunity and altered the gut microflora in mice immunized by H1N1 influenza vaccine},
journal = {PeerJ},
year = {2023},
volume = {11},
pages = {e16226},
doi = {10.7717/peerj.16226}
}
EUVIMED